Manufacturing company IDEX (NYSE: IEX) beat Wall Street’s revenue expectations in Q1 CY2026, with sales up 8.9% year on year to $886.9 million. Guidance for next quarter’s revenue was better than expected at $895.7 million at the midpoint, 0.8% above analysts’ estimates. Its non-GAAP profit of $2 per share was 12.9% above analysts’ consensus estimates.

Is now the time to buy IEX? Find out in our full research report (it’s free for active Edge members).

StockStory’s Take

IDEX’s first quarter results were met with a positive market reaction, as management pointed to substantial growth in Health & Science Technologies (HST) and robust order activity across its core segments. CEO Eric Ashleman credited the quarter’s performance to strong execution in targeted end markets, particularly data center, semiconductor, and space and defense applications. Orders grew organically by 10%, with HST leading at 17%, demonstrating that the company’s recent portfolio shift toward high-value, durable markets is gaining traction. Management also highlighted disciplined cost control and the ongoing deployment of the 8020 strategy, which focuses resources on the most promising customers and applications.

Looking ahead, IDEX’s updated outlook is supported by a solid backlog in HST and management’s expectation of continued strength in data center, semiconductor, and space and defense segments. CFO Sean Gillen stated, “Our guidance assumes high single-digit growth in HST and stability in FMT and FSDP, reflecting the robust order book and improving industrial trends.” Management remains cautious regarding macroeconomic headwinds and geopolitical uncertainty, but believes that investments in advantaged markets and ongoing productivity initiatives will drive margin improvements and sustained earnings growth throughout 2026.

Key Insights from Management’s Remarks

Management attributed the quarter’s solid results to strategic expansion in high-growth sectors, disciplined execution, and targeted capital allocation, while noting ongoing order strength in advantaged markets.

• HST Segment Drives Growth: The Health & Science Technologies segment benefited from secular demand in data center, semiconductor, and space and defense markets. Management emphasized that co-engineering with customers and early-stage involvement in mission-critical solutions were key contributors to revenue and order backlog.

• 8020 Strategy Implementation: The company’s 8020 strategy—focusing on the most valuable customers and applications—continued to shape portfolio decisions, enabling targeted resource allocation and higher-margin growth. Management highlighted that “doubling down on fewer customers” is increasing growth rates and operational efficiency.

• Order Momentum and Backlog Build: Organic orders rose 10% overall, with notable outperformance in HST and Fluid & Metering Technologies (FMT). This backlog expansion provides enhanced visibility for the remainder of 2026, especially in platforms exposed to long-cycle, durable end markets.

• Productivity and Margin Expansion: Year-over-year margin improvement was attributed to productivity gains, positive volume leverage, and disciplined cost control. While the mix was a modest headwind, management expects ongoing productivity initiatives to support further margin gains.

• Capital Deployment and M&A Activity: IDEX continued a balanced approach to capital, maintaining share repurchases and dividends while pursuing bolt-on acquisitions. Management noted that recent acquisitions, such as Mott and Muon, are contributing to growth but require further integration to match segment-average margins.

Drivers of Future Performance

IDEX’s guidance for 2026 is built on durable demand in HST, continued operational efficiency, and selective capital deployment, tempered by macroeconomic and geopolitical uncertainties.

• Sustained HST Demand: Management expects high single-digit growth in HST, driven by ongoing strength in data center, semiconductor, and defense-related applications. The company’s deepening customer relationships and backlog visibility are expected to anchor growth for both 2026 and beyond.

• Stable FMT and FSDP Outlook: Fluid & Metering Technologies and Fire & Safety/Diversified Products are modeled for relatively flat growth, reflecting short-cycle industrial exposure and lingering uncertainty in chemicals and core energy markets. Management remains guarded about a full recovery until geopolitical risks subside.

• Margin Leverage and Integration: Ongoing productivity efforts, portfolio pruning, and integration of recent acquisitions are expected to drive incremental margin improvement. Management highlighted that further progress in acquired units and a pickup in life sciences would enhance overall segment profitability, with mid-30% incremental margins in HST anticipated for the year.

Catalysts in Upcoming Quarters

Looking ahead, the StockStory team will be monitoring (1) sustained backlog growth and order momentum in HST as a sign of continued demand in advantaged markets, (2) sequential improvement and recovery signs in short-cycle FMT and FSDP businesses, and (3) incremental margin gains from portfolio integration and productivity initiatives. Progress on bolt-on M&A and the ability to navigate macroeconomic uncertainties will also be important indicators.

IDEX currently trades at $216.77, up from $205.36 just before the earnings. Is there an opportunity in the stock?Find out in our full research report (it’s free).

Our Favorite Stocks Right Now

ALSO WORTH WATCHING: Top 5 Momentum Stocks. The best time to own a great stock is when the market is finally noticing it. These aren't just high-quality businesses. Something is happening with them right now. Elite fundamentals meeting near-term momentum - both boxes checked at the same time.

Find out which stocks our AI platform is flagging this week. See this week's Strong Momentum stocks - FREE. Get Our Strong Momentum Stocks for Free HERE.

Stocks that have made our list include now familiar names such as Nvidia (+1,326% between June 2020 and June 2025) as well as under-the-radar businesses like the once-small-cap company Comfort Systems (+782% five-year return). Find your next big winner with StockStory today.